Literature DB >> 24748607

Exchanging care records using HL7 V3 care provision messages.

William Goossen1, Laura Heermann Langford2.   

Abstract

OBJECTIVE: This paper describes Health Level 7 (HL7) V.3 Care Transfer, Care Record Query, and Care Record messages. This is the core of the Care Provision Domain in the HL7 standard which became normative at the end of 2012 and is an American National Standards Institute (ANSI)-approved HL7 standard. BACKGROUND AND SIGNIFICANCE: Using a message is somewhat different from the approach offered in the current HL7 Clinical Document Architecture (CDA). The overall advantage is human-to-human communication and system-to-system processing of structured data through electronic messages, supporting continuity of care and interactive structured data exchange through querying.
MATERIALS AND METHODS: The Care Provision Domain Model in HL7 was developed based on use cases from several projects internationally. Use case and information analysis, model building, HL7 consensus methods (eg, working group meetings), conference calls, balloting, a draft standard for trial use, pilot implementations, and subsequent evaluation were applied.
RESULTS: The membership and pilot implementers gave feedback to improve the draft standard. After the formal ballot process, HL7 membership accepted it as a normative standard and it is now ANSI approved. The Care Provision Domain Model defines the structure (data exchanged) and dynamics (workflow and communications) of the Care Record, Care Record Query, and Care Transfer. DISCUSSION AND
CONCLUSIONS: The HL7 V3 Care Provision Domain differs from the HL7 CDA regarding support of the dynamics of care (eg, for continuity of care) as provided through a series of interactions and queries, but is similar with respect to the data and their organization. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2014        PMID: 24748607      PMCID: PMC4173169          DOI: 10.1136/amiajnl-2013-002264

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  5 in total

1.  The HL7 Clinical Document Architecture.

Authors:  R H Dolin; L Alschuler; C Beebe; P V Biron; S L Boyer; D Essin; E Kimber; T Lincoln; J E Mattison
Journal:  J Am Med Inform Assoc       Date:  2001 Nov-Dec       Impact factor: 4.497

2.  Electronic patient records: domain message information model perinatology.

Authors:  William T F Goossen; Marcel J Jonker; Kai U Heitmann; Irma C Jongeneel-de Haas; Tom de Jong; Johannes W van der Slikke; Bert L Kabbes
Journal:  Int J Med Inform       Date:  2003-07       Impact factor: 4.046

3.  Model once, use multiple times: reusing HL7 domain models from one domain to the other.

Authors:  William Goossen
Journal:  Stud Health Technol Inform       Date:  2004

4.  HL7 Clinical Document Architecture, Release 2.

Authors:  Robert H Dolin; Liora Alschuler; Sandy Boyer; Calvin Beebe; Fred M Behlen; Paul V Biron; Amnon Shabo Shvo
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

5.  HL7 version 3--an object-oriented methodology for collaborative standards development.

Authors:  G W Beeler
Journal:  Int J Med Inform       Date:  1998-02       Impact factor: 4.046

  5 in total
  2 in total

1.  iT2DMS: a Standard-Based Diabetic Disease Data Repository and its Pilot Experiment on Diabetic Retinopathy Phenotyping and Examination Results Integration.

Authors:  Huiqun Wu; Yufang Wei; Yujuan Shang; Wei Shi; Lei Wang; Jingjing Li; Aimin Sang; Lili Shi; Kui Jiang; Jiancheng Dong
Journal:  J Med Syst       Date:  2018-06-06       Impact factor: 4.460

2.  PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer.

Authors:  Ioannis Tamposis; Ioannis Tsougos; Anastasios Karatzas; Katerina Vassiou; Marianna Vlychou; Vasileios Tzortzis
Journal:  Appl Clin Inform       Date:  2022-01-19       Impact factor: 2.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.